- 1. 1 or More Positive Axillary Nodes
- [Presence of one or more lymph nodes in the area of the armpit in which cancerous cells have been detected. ( NCI )] (UMLS (NCI) C0279784) =Finding
| - 51. oral surgeon
- [A dentist with special training in surgery of the mouth and jaw. ( NCI )] (UMLS (NCI) C0260272) =Professional or Occupational Group
|
- 2. 37 or more completed weeks of gestation
- [ ] (UMLS (ICD9CM) C1135248) 37+ COMP WKS GESTATION;
=Temporal Concept | - 52. Oral Surgery
- [A dental specialty concerned with the diagnosis and surgical treatment of disease, injuries, and defects of the human oral and maxillofacial region. ( MSH )] (UMLS (NCI) C0038908) =Biomedical Occupation or Discipline
|
- 3. or
- [An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise. ( NCI )] (UMLS (HL7) C1518602) =Idea or Concept ;
=RelationshipConjunction;
| - 53. oral tolerance
- [state of immunologic unresponsiveness induced by the prior ingestion of antigen. ( CSP )] (UMLS (CSP) C0597140) =Organism Attribute ;
=immune tolerance/unresponsiveness;
|
- 4. OR
- [A state in the northwestern United States. Its capital is Salem. ( NCI )] (UMLS (NCI) C0029195) =Geographic Area ;
| - 54. oral tolerization
- [ ] (UMLS (CSP) C0599028) =Organism Function ;
|
- 5. OR Nursing
- [Nursing care of the surgical patient before, during, and after surgery. ( NCI )] (UMLS (NCI) C0038931) =Biomedical Occupation or Discipline
| - 55. Oramorph SR
- (UMLS (NCI) C0700785) =Organic Chemical; Pharmacologic Substance
|
- 6. Ora Testryl
- (UMLS (NCI) C0733926) Ora-Testryl =Steroid; Pharmacologic Substance; Hormone
| - 56. ORANGE
- [The hue of that portion of the visible spectrum lying between red and yellow, evoked in the human observer by radiant energy with wavelengths of approximately 590 to 630 nanometers; any of a group of colors between red and yellow in hue, of medium lightness and moderate saturation. ( NCI )] (UMLS (NCI) C1313858) =Qualitative Concept; ;
|
- 7. Oral
- [Oral ( HL7V3.0 )] (UMLS (HL7) C0205531) =Functional Concept =drug administration route;
RouteBySite =Chew, oral;
Dissolve, oral;
Inhalation, intrapulmonary;
Rinse, oral;
Swallow, oral;
Topical application, oral | - 57. Orange Juice
- (UMLS (NCI) C0452458) =Food =Unclassified Ingredients;
Inactive Ingredient Preparations =COMPLEAT MODIFIED LIQUID;
COMPLEAT MODIFIED LIQUID (CLOSED SYSTEM);
COMPLEAT REGULAR FORMULA LIQUID;
COMPLEAT REGULAR LIQUID (CLOSED SYSTEM);
|
- 8. oral
- [By or having to do with the mouth. ( NCI )] (UMLS (NCI) C0442027) =Spatial Concept
| - 58. orangutan
- [The single species of orangutan belonging to the HOMINIDAE family and found only in lowland forests of Sumatra and Borneo. Among the PRIMATES, the orangutan is second in size only to the gorilla (GORILLA GORILLA). ( MSH )] (UMLS (CSP) C0032638) =Mammal
|
- 9. Oral & Maxillofacial Surgery
- (UMLS (HL7) C1555793) =Professional or Occupational Group =Allopathic & Osteopathic Physicians;
| - 59. Orap
- (UMLS (NCI) C0591918) =Organic Chemical; Pharmacologic Substance ;
|
- 10. oral administration
- [route of drug or nutrient intake via the mouth. ( CSP )] (UMLS (CSP) C0001563) =Therapeutic or Preventive Procedure ;
| - 60. Orasone
- (UMLS (NCI) C0728771) =Steroid; Pharmacologic Substance ;
|
- 11. oral airflow measurement
- [ ] (UMLS (CSP) C0599319) =Diagnostic Procedure ;
| - 61. ORB _ Blood product order acknowledgment
- (UMLS (HL7) C1549264) =Health Care Activity =Event Type;
|
- 12. Oral and Maxillofacial Pathology
- [The specialty of dentistry and discipline of pathology that deals with the nature, identification, and management of diseases affecting the oral and maxillofacial regions. It is a science that investigates the causes, processes, and effects of these diseases. The practice of oral and maxillofacial pathology includes research and diagnosis of diseases using clinical, radiographic, microscopic, biochemical, or other examinations.Source: Council on Dental Education and Licensure, American Dental Association ( HL7V3.0 )] (UMLS (HL7) C1555930) =Intellectual Product =Dentist;
| - 62. Orbicularis Oculi
- (UMLS (NCI) C0224122) =Body Part, Organ, or Organ Component
|
- 13. Oral and Maxillofacial Radiology
- [The specialty of dentistry and discipline of radiology concerned with the production and interpretation of images and data produced by all modalities of radiant energy that are used for the diagnosis and management of diseases, disorders and conditions of the oral and maxillofacial region.Source: Council on Dental Education and Licensure, American Dental Association ( HL7V3.0 )] (UMLS (HL7) C1555931) =Intellectual Product =Dentist;
| - 63. Orbiculus Ciliaris
- (UMLS (NCI) C0229167) =Body Part, Organ, or Organ Component
|
- 14. Oral and Maxillofacial Surgery
- [The specialty of dentistry which includes the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.Source: Council on Dental Education and Licensure, American Dental Association ( HL7V3.0 )] (UMLS (HL7) C1552440) =Manufactured Object; Health Care Related Organization =Clinic/Center;
| - 64. Orbit Paraganglioma
- [A benign or malignant extra-adrenal paraganglioma arising from the orbit. Patients may present with visual disturbances or proptosis. ( NCI )] (UMLS (NCI) C1335130) Orbital Paraganglioma;
Paraganglioma of Orbit;
Paraganglioma of the Orbit =Neoplastic Process ;
|
- 15. Oral and Maxillofacial Surgery
- [The specialty of dentistry which includes the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.Source: Council on Dental Education and Licensure, American Dental Association ( HL7V3.0 )] (UMLS (HL7) C1555932) =Professional or Occupational Group =Dentist;
| - 65. Orbit Rhabdomyosarcoma
- [A malignant mesenchymal tumor with skeletal muscle differentiation affecting the orbit. ( NCI )] (UMLS (NCI) C0346347) =Neoplastic Process
|
- 16. oral bacteria
- [see RTs for specific organisms. ( CSP )] (UMLS (CSP) C0597134) =Bacterium ;
=bacteria characteristic;
| - 66. Orbit Sarcoma
- (UMLS (NCI) C1335131) Orbital Sarcoma;
Sarcoma of Orbit;
Sarcoma of the Orbit;
=Neoplastic Process ;
|
- 17. oral behavior
- [any behaviors involving the mouth; includes the response of the mammalian infant to draw milk from the breast, sucking on inanimate objects, nail biting, thumb sucking, chewing, etc. ( CSP )] (UMLS (CSP) C0178781) =Individual Behavior =behavior;
=eating;
chewing | - 67. Orbit/Orbital
- (UMLS (HL7) C1550285) =Body Part, Organ, or Organ Component =Body Part;
|
- 18. ORAL BISPHOSPHONATES
- [ ] (UMLS (ICD9CM) C1955565) =Injury or Poisoning
| - 68. ORBITAL CELLULITIS
- [Inflammation of the loose connective tissues around the ORBIT, bony structure around the eyeball. It is characterized by PAIN; EDEMA of the CONJUNCTIVA; swelling of the EYELIDS; EXOPHTHALMOS; limited eye movement; and loss of vision. ( MSH )] (UMLS (ICD9CM) C0149507) =Disease or Syndrome
|
- 19. Oral Cancer Prevention
- (UMLS (NCI) C0678094) =Therapeutic or Preventive Procedure
| - 69. ORBITAL CYSTS
- [ ] (UMLS (ICD9CM) C0155285) =Acquired Abnormality; Disease or Syndrome
|
- 20. Oral Cavity and Lip Precancerous Condition
- (UMLS (NCI) C1335125) Oral Cavity and Lip Premalignant Condition =Disease or Syndrome ;
| - 70. ORBITAL DISORDERS NEC
- [ ] (UMLS (ICD9CM) C0155284) =Disease or Syndrome ;
|
- 21. Oral Cavity Benign Granular Cell Neoplasm
- (UMLS (NCI) C1335117) Oral Cavity Benign Granular Cell Tumor =Neoplastic Process ;
| - 71. ORBITAL EDEMA
- (UMLS (ICD9CM) C0424813) =Pathologic Function
|
- 22. ORAL CAVITY DX PROC NEC
- [ ] (UMLS (ICD9CM) C0176436) =Diagnostic Procedure
| - 72. ORBITAL EXENTERATION NEC
- [ ] (UMLS (ICD9CM) C0176297) =Therapeutic or Preventive Procedure
|
- 23. Oral Cavity Finding
- (UMLS (NCI) C0455788) =Finding
| - 73. ORBITAL GRANULOMA
- [ ] (UMLS (ICD9CM) C0155262) =Disease or Syndrome ;
|
- 24. ORAL CAVITY OPS NEC
- [ ] (UMLS (ICD9CM) C0176453) =Therapeutic or Preventive Procedure
| - 74. ORBITAL HEMORRHAGE
- [ ] (UMLS (ICD9CM) C0155268) =Pathologic Function ;
|
- 25. Oral Cavity Submucous Fibrosis
- (UMLS (NCI) C0029171) =Disease or Syndrome ;
| - 75. ORBITAL OSTEOMYELITIS
- [ ] (UMLS (ICD9CM) C0155258) =Disease or Syndrome ;
|
- 26. oral cholecystography
- [ ] (UMLS (CSP) C0203079) =Diagnostic Procedure
| - 76. Orbital Part of the Inferior Frontal Gyrus
- (UMLS (NCI) C0262300) =Body Part, Organ, or Organ Component
|
- 27. Oral Complications of Cancer and Cancer Therapy
- (UMLS (NCI) C1321873) =Finding ;
| - 77. ORBITAL PERIOSTITIS
- [ ] (UMLS (ICD9CM) C0155257) =Disease or Syndrome ;
|
- 28. Oral Complications of Chemotherapy and Head and Neck Radiation
- (UMLS (NCI) C0879594) =Injury or Poisoning
| - 78. Orbital Sulcus
- (UMLS (NCI) C0228206) =Body Space or Junction
|
- 29. Oral Contraceptive
- [Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. ( MSH )] (UMLS (NCI) C0009905) =Pharmacologic Substance ;
| - 79. ORBITAL TENONITIS
- [ ] (UMLS (ICD9CM) C0155259) =Disease or Syndrome ;
|
- 30. Oral Contraceptive Preparation
- [Orally administered synthetic sex hormones with contraceptive activity. The oral contraceptive preparation contains a combination of an estrogen, such as ethinyl estradiol, and a progestagen, such as levonorgestrel or norethidrone. The oral contraceptive prevents pregnancy by preventing ovulation and by inducing endometrial and cervical changes undesirable for fertilization and implantation. ( NCI )] (UMLS (NCI) C0009906) =Pharmacologic Substance ;
| - 80. Orbitalis Muscle
- (UMLS (NCI) C0229105) =Body Part, Organ, or Organ Component
|
- 31. Oral Contraceptives
- (UMLS (HL7) C1548892) =Health Care Activity =Consent Type;
| - 81. Orbitotomy
- [ ] (UMLS (ICD9CM) C0152462) =Therapeutic or Preventive Procedure
|
- 32. Oral Dosage Form
- [Different formulations for oral administration include solutions, suspensions, capsules, compressed tablets, coated medications and controlled release dosage forms. The availability of a drug for absorption is maximal in solutions and decreases in descending order with suspensions, capsules, compressed tablets, and coated tablets, respectively. ( NCI )] (UMLS (NCI) C1272919) Oral Dose Form;
=Biomedical or Dental Material ;
| - 82. ORBITOTOMY NEC
- [ ] (UMLS (ICD9CM) C0176291) =Therapeutic or Preventive Procedure
|
- 33. oral facial pain
- [pain in the oral and/or facial regions; associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. ( CSP )] (UMLS (CSP) C0178782) =Sign or Symptom =pain;
=Fothergill's neuralgia;
| - 83. ORBITOTOMY W BONE FLAP
- [ ] (UMLS (ICD9CM) C0196955) =Therapeutic or Preventive Procedure
|
- 34. oral facial reconstruction
- [ ] (UMLS (CSP) C1537037) =Therapeutic or Preventive Procedure ;
| - 84. ORBITOTOMY W IMPLANT
- [ ] (UMLS (ICD9CM) C0176290) =Therapeutic or Preventive Procedure
|
- 35. oral facial restoration
- [procedures used to reconstruct, restore, or improve, damaged, or missing orofacial structures. ( CSP )] (UMLS (CSP) C0597135) =Therapeutic or Preventive Procedure ;
=plastic surgery;
| - 85. Orbivirus
- [genus of Reoviridae infecting a wide range of arthropods and vertebrates including humans; comprises at least twelve serological subgroups; transmission is by vectors such as midges, mosquitoes, sandflies, and ticks. ( CSP )] (UMLS (CSP) C0206592) =Virus ;
=Reoviridae;
|
- 36. oral facial restoration material
- [materials contained in temporary or permanent cleft palate prostheses and oral facial restoration; may be an implant, biomaterial or prosthetic device. ( CSP )] (UMLS (CSP) C0597136) =Biomedical or Dental Material ;
=biomaterial;
| - 86. Orbivirus Infection
- (UMLS (NCI) C1142183) =Disease or Syndrome
|
- 37. Oral Fluorouracil-Uracil
- [A formulated therapeutic oral agent consisting of a combination of tetrahydrofuranyl-5-fluorouracil and uracil (1:4). Tetrahydrofuranyl-5-fluorouracil, the congener prodrug of 5-fluorouracil (5-FU), is metabolized to 5-FU either by hepatic cytochrome P-450 enzymes or by ubiquitous cytosolic enzymes in the body. Because of its higher concentration in the combination, uracil saturates the uracil-reducing enzymatic activity of dihydropyrimidine dehydrogenase, thereby inhibiting first-pass dihydropyrimidine dehydrogenase-mediated hepatic metabolism of the uracil analogue, 5-FU, and permitting prolonged concentration of 5-FU in tumor tissue. 5-FU inhibits the enzyme thymidylate synthase, thereby decreases available thymidine nucleotide. As a result, DNA synthesis is inhibited and tumor cell proliferation is blocked. ( NCI )] (UMLS (NCI) C1446539) Tegafur-Uracil;
UFT;
Uracil and Ftorafur;
Uracil and Tegafur;
Uracil and Tetrahydrofuranyl-5-Fluorouracil;
Uracil/Tegafur (UFT) =Organic Chemical; Pharmacologic Substance | - 87. ORC group
- (UMLS (HL7) C1550164) =Idea or Concept =Segment group;
|
- 38. oral health service
- [A clinical Invoice Grouping consisting of one or more oral health services. Billing for these service(s) are supported by multiple clinical billable events (acts). All items in the Invoice Grouping must be adjudicated together to be acceptable to the Adjudicator. ( HL7V3.0 )] (UMLS (HL7) C1552565) =Intellectual Product ;
=ActInvoiceRootGroupCode;
| - 88. ORC Subunit Gene
- [DNA replication is initiated by the Origin Recognition Complex (ORC). ORC is composed of six protein subunits and binds to the ARS Consensus Sequence (ACS) of Origins of Replication in an ATP-dependent manner. While ORC remains bound to origins throughout the cell cycle, the binding of ORC and other factors modulates local chromatin structure to facilitate replication initiation. All 6 genes encoding ORC (ORC1 through ORC6) may be required for initiation of DNA replication and are essential for viability. ( NCI )] (UMLS (NCI) C1335089) =Gene or Genome
|
- 39. Oral Mucosa Lobular Capillary Hemangioma
- [A lobular hemangioma arising from the oral mucosa. ( NCI )] (UMLS (NCI) C0267019) =Disease or Syndrome
| - 89. ORC1L
- [This gene plays a role in DNA binding, initiation of DNA replication and transcriptional silencing. It is also involved in ATP hydrolysis and the maintenance of cell viability. ( NCI )] (UMLS (NCI) C1335083) ORC1L Gene;
Origin Recognition Complex, Subunit 1-Like (Yeast) Gene;
=Gene or Genome ;
|
- 40. Oral Pathology
- [A dental specialty concerned with pathology of the oral cavity. ( MSH )] (UMLS (NCI) C0030668) =Biomedical Occupation or Discipline
| - 90. ORC2
- [Expression (testes highest) not regulated during cell proliferation, human ORC2L Gene (ORC2 Family) encodes 577-aa 66-kDa nuclear Origin Recognition Complex Subunit 2, one of 6 conserved subunits of the ORC complex that binds to the consensus ACS of Origins in an ATP-dependent manner, serves as a platform for assembly of additional initiation factors such as CDC6 and MCM proteins, initiates DNA replication, and is essential for viability. Bound to origins throughout the cell cycle, ORC and associated factors modulate local chromatin structure to facilitate replication initiation. ORC2L forms a core ORC complex with ORC1L, -3L, -4L, and -5L, interacts with CDC45L and MCM10 (important for replication initiation), and has a role in transcriptional silencing. (NCI) ( NCI )] (UMLS (NCI) C1335135) ORC2L;
Origin of Replication 2 Homolog-Like;
Origin Recognition Complex Protein 2 Homolog;
Origin Recognition Complex Subunit 2;
Origin Recognition Complex Subunit 2-Like;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 41. oral pharyngeal
- [region of the stomatognathic system and the gastrointestinal system that extends from the lips, past the soft palate and to the epiglottis; also refers to the specific anatomical portion of pharynx, oropharynx, that is below the soft palate and above the epiglottis and is continuous with the mouth. ( CSP )] (UMLS (CSP) C0521367) =Body Location or Region =head;
pharynx;
Body Part;
=Head and Neck, Salivary Glands;
Buccal Cavity;
dental structure | - 91. ORC2L
- [This gene is involved in DNA binding and the initiation of DNA replication. It also plays a role in negative control of transcription. ( NCI )] (UMLS (NCI) C1335084) ORC2L Gene;
Origin Recognition Complex, Subunit 2-Like (Yeast) Gene;
=Gene or Genome ;
|
- 42. oral pharyngeal disorder
- [impairment of health or a condition of abnormal functioning of a region of the pharynx that is below the soft palate and above the epiglottis and is continuous with the mouth. ( CSP )] (UMLS (CSP) C0553694) =Disease or Syndrome =Gastrointestinal Diseases;
=Neoplasm of Oropharynx;
pharyngitis;
Diseases of the salivary glands;
stomatitis;
oral pharyngeal hyperplasia | - 92. ORC3L
- [This gene plays a role in DNA binding and the initiation of DNA replication. It is also involved in transcriptional silencing. ( NCI )] (UMLS (NCI) C1335085) ORC3L Gene;
Origin Recognition Complex, Subunit 3-Like (Yeast) Gene;
=Gene or Genome |
- 43. oral pharyngeal disorder diagnosis
- [determination of an impairment of health or a condition of abnormal functioning of oral pharynx based on symptoms, medical history, risk factors, and clinical tests; oral pharyngeal refers to the region of the body between the lips and the oropharynx, which is pharynx below the soft palate and above the epiglottis. ( CSP )] (UMLS (CSP) C0178783) =Diagnostic Procedure =gastrointestinal disorder diagnosis;
=dental disorder diagnosis;
| - 93. ORC4
- [Human ORC4L Gene (ORC4 Family) encodes 436-aa 50-kDa nuclear Origin Recognition Complex Subunit 4, one of 6 conserved subunits of the ORC complex that binds to the consensus ACS of Origins in an ATP-dependent manner, serves as a platform for assembly of additional initiation factors such as CDC6 and MCM proteins, initiates DNA replication, and is essential for viability. Bound to origins throughout the cell cycle, ORC and associated factors modulate local chromatin structure to facilitate replication initiation. ORC4L has a putative nucleotide triphosphate binding motif, associates with multiple cellular proteins, forms a core ORC complex with ORC2L, -3L, and -5L, and has a role in transcriptional silencing. (NCI) ( NCI )] (UMLS (NCI) C1335136) ORC4L;
ORC4P;
Origin Recognition Complex Subunit 4;
Origin Recognition Complex Subunit 4-Like =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 44. oral pharyngeal hyperplasia
- [increase in the number of cells in the oral pharynx without tumor formation; it differs from hypertrophy, which is an increase in bulk without an increase in the number of oral pharynx cells; oral pharyngeal refers to the region of the body between the lips and the oropharynx, which is pharynx below the soft palate and above the epiglottis. ( CSP )] (UMLS (CSP) C0597138) =Disease or Syndrome ;
=hyperplasia;
oral pharyngeal disorder =gingiva hyperplasia;
Leukokeratosis of Oral Mucosa | - 94. ORC4L
- [This gene is involved in DNA binding, initiation of DNA replication and transcriptional silencing. It also plays a role in ATP hydrolysis and the maintenance of cell viability. ( NCI )] (UMLS (NCI) C1335086) ORC4L Gene;
Origin Recognition Complex, Subunit 4-Like (Yeast) Gene;
=Gene or Genome |
- 45. oral pharyngeal surgery
- [procedures performed on the oral pharyngeal areas, used in the treatment of disease, injuries, or deformities; oral pharyngeal refers to the region of the body between the lips and the oropharynx, which is pharynx below the soft palate and above the epiglottis, including dental structures. ( CSP )] (UMLS (CSP) C0597139) =Therapeutic or Preventive Procedure ;
=gastrointestinal surgery;
=Extraction of Tooth;
| - 95. ORC5
- [Abundantly expressed in spleen, ovary, testes, colon mucosa, and prostate, human ORC5L Gene (ORC5 Family) encodes 435-aa 50-kDa nuclear Origin Recognition Complex Subunit 5, one of 6 conserved subunits of the ORC complex that binds to the consensus ACS of Origins in an ATP-dependent manner, serves as a platform for assembly of additional initiation factors such as CDC6 and MCM proteins, initiates DNA replication, and is essential for viability. Bound to origins throughout the cell cycle, ORC and associated factors modulate local chromatin structure to facilitate replication initiation. While ORC5 forms a core ORC complex with ORC2L, -3L, and -4L, the ORC5T isoform interacts with ORC4L, but not ORC2L, and regulates assembly of different ORC subcomplexes. ORC5 has a role in transcriptional silencing. (NCI) ( NCI )] (UMLS (NCI) C1335137) ORC5L;
ORC5P;
ORC5T;
Origin Recognition Complex Subunit 5;
Origin Recognition Complex Subunit 5-Like;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 46. Oral Prosthesis
- (UMLS (NCI) C0935659) =Medical Device
| - 96. ORC5L
- [This gene plays a role in DNA binding and the initiation of DNA replication. It is also involved in negative regulation of transcription. ( NCI )] (UMLS (NCI) C1335087) ORC5L Gene;
Origin Recognition Complex, Subunit 5-Like (Yeast) Gene;
=Gene or Genome |
- 47. oral pulvinar nucleus
- [ ] (UMLS (CSP) C0262299) =Body Part, Organ, or Organ Component
| - 97. ORC6
- [Expressed throughout the cell cycle, human ORC6L Gene (ORC6 Family) encodes nuclear 252-aa 28-kDa Origin Recognition Complex Subunit 6, one of 6 conserved subunits of the ORC complex that binds to the consensus ACS of Origins in an ATP-dependent manner, serves as a platform for assembly of additional initiation factors such as CDC6 and MCM proteins, initiates DNA replication, and is essential for viability. Bound to origins throughout the cell cycle, ORC and associated factors modulate local chromatin structure to facilitate replication initiation. While ORC6L and ORC1L loosely associate with the core ORC complex of ORC2L, -3L, -4L and -5L, ORC6 also interacts with other proteins, including a 65-kDa hyperphosphoprotein (G1) dephosphorylated in mitosis. Essential in coordinating chromosome replication/segregation with cytokinesis, ORC6L also has a role in transcriptional silencing. (NCI) ( NCI )] (UMLS (NCI) C1335138) ORC6L;
Origin Recognition Complex Subunit 6;
Origin Recognition Complex Subunit 6 Homolog-Like;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 48. oral reconstruction
- [ ] (UMLS (CSP) C1537038) =Therapeutic or Preventive Procedure ;
| - 98. ORC6L
- [This gene is involved in DNA binding, initiation of DNA replication and transcriptional silencing. ( NCI )] (UMLS (NCI) C1335088) ORC6L Gene;
Origin Recognition Complex, Subunit 6 Homolog-Like (Yeast) Gene;
=Gene or Genome |
- 49. oral rehydration therapy
- [ ] (UMLS (CSP) C0029168) =Therapeutic or Preventive Procedure ;
| - 99. Orcein stain
- [Stain, Orcein ( HL7V3.0 )] (UMLS (HL7) C1294001) =Laboratory Procedure =ObservationMethod;
|
- 50. ORAL SOFT TISSUE DIS NEC
- [ ] (UMLS (ICD9CM) C0029498) =Disease or Syndrome
| - 100. orchidopexy
- [ ] (UMLS (CSP) C0194907) =Therapeutic or Preventive Procedure
|
home
